139 related articles for article (PubMed ID: 29703492)
1. Predictive factors of fatal bleeding in acute promyelocytic leukemia.
Mantha S; Tallman MS; Devlin SM; Soff GA
Thromb Res; 2018 Apr; 164 Suppl 1():S98-S102. PubMed ID: 29703492
[TBL] [Abstract][Full Text] [Related]
2. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
3. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
4. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
[TBL] [Abstract][Full Text] [Related]
5. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
7. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
[TBL] [Abstract][Full Text] [Related]
8. Hemorrhage in acute promyelocytic leukemia: Can it be predicted and prevented?
Naymagon L; Mascarenhas J
Leuk Res; 2020 Jul; 94():106356. PubMed ID: 32445941
[TBL] [Abstract][Full Text] [Related]
9. Advances in the management of coagulopathy in acute promyelocytic leukemia.
Sanz MA; Montesinos P
Thromb Res; 2020 Jul; 191 Suppl 1():S63-S67. PubMed ID: 32736781
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
11. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy.
Abla O; Ribeiro RC; Testi AM; Montesinos P; Creutzig U; Sung L; Di Giuseppe G; Stephens D; Feusner JH; Powell BL; Hasle H; Kaspers GJL; Dalla-Pozza L; Lassaletta A; Tallman MS; Locatelli F; Reinhardt D; Lo-Coco F; Hitzler J; Sanz MA
Ann Hematol; 2017 Sep; 96(9):1449-1456. PubMed ID: 28597167
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid.
Singh C; Karunakaran P; Yanamandra U; Jindal N; Kumar SR; Saini N; Jandial A; Jain A; Lad D; Prakash G; Khadwal A; Kumar N; Naseem S; Ahluwalia J; Varma N; Varma S; Malhotra P
Leuk Res; 2023 Nov; 134():107392. PubMed ID: 37774447
[TBL] [Abstract][Full Text] [Related]
14. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
15. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
16. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
Sahai T; Henrichs K; Refaai M; Heal JM; Kirkley SA; Schmidt AE; Mendler JH; Masel D; Liesveld J; Aquina C; Blumberg N
Leuk Res; 2017 Nov; 62():1-3. PubMed ID: 28963906
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between D-Dimer/Fibrinogen Ratio and Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Li SS; Yang XW; Zheng Y; Gao YJ; Su YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1340-1344. PubMed ID: 37846682
[TBL] [Abstract][Full Text] [Related]
19. What's new in the pathogenesis of the coagulopathy in acute promyelocytic leukemia?
Mantha S; Tallman MS; Soff GA
Curr Opin Hematol; 2016 Mar; 23(2):121-6. PubMed ID: 26760586
[TBL] [Abstract][Full Text] [Related]
20. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]